Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder J.H. Whitney Equity Partners V Sells 2,419,035 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the business’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total value of $19,376,470.35. Following the completion of the transaction, the insider owned 10,112,123 shares of the company’s stock, valued at $80,998,105.23. This trade represents a 19.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.00, for a total value of $7,355,112.00.
• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total value of $36,455,577.60.

Aveanna Healthcare Price Performance

Shares of NASDAQ:AVAH opened at $9.10 on Friday. The company has a market cap of $1.98 billion, a P/E ratio of 7.71, a P/E/G ratio of 0.91 and a beta of 1.89. The business has a fifty day simple moving average of $7.31 and a 200-day simple moving average of $7.56. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company had revenue of $647.91 million during the quarter, compared to analysts’ expectations of $613.22 million. The business’s revenue for the quarter was up 15.9% compared to the same quarter last year. Equities research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of AVAH. Caitong International Asset Management Co. Ltd increased its position in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares in the last quarter. Summit Securities Group LLC purchased a new stake in Aveanna Healthcare during the 1st quarter worth $53,000. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare during the 2nd quarter worth $43,000. EverSource Wealth Advisors LLC increased its holdings in Aveanna Healthcare by 88,100.0% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock valued at $102,000 after purchasing an additional 11,453 shares in the last quarter. Finally, Entropy Technologies LP acquired a new stake in Aveanna Healthcare in the 3rd quarter valued at $107,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a research note on Friday, March 20th. Weiss Ratings downgraded Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. BMO Capital Markets cut their target price on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Barclays reduced their target price on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday, May 18th. Finally, Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $10.00 to $11.00 in a research report on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.